Brief: Neurocrine Biosciences Inc If Deal Terminated Under Some Circumstances Soleno Will Pay Co Termination Fee Of $95.3 Million
06/04/2026 12:39
April 6 (Reuters) - Neurocrine Biosciences Inc NBIX.O: NEUROCRINE BIOSCIENCES INC: IF DEAL TERMINATED UNDER SOME CIRCUMSTANCES SOLENO WILL PAY CO TERMINATION FEE OF $95.3 MILLION NEUROCRINE BIOSCIENCES INC: IF DEAL TERMINATED UNDER CERTAIN CIRCUMSTANCES, CO TO PAY SOLENO REVERSE TERMINATION FEE OF $141.5 MILLION - SEC FILING Source text: [ID:n0001193125-26-142904] Further company coverage: NBIX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Neurocrine Biosciences
See all newsBrief: Neurocrine Biosciences Initiates Phase 2 Clinical Study Evaluating Nbi-'567 In Adults With Alzheimer's Disease
Nxera Pharma's Partner Neurocrine Biosciences Receives Ind Acceptance From FDA For Phase 2 Study Of Nbi-1117567 For Alzheimer's Cognition
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte, CoreWeave
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte
Prader-Willi groups cite deaths tied to Neurocrine's genetic disorder drug, shares fall